Intended for healthcare professionals


Sixty seconds on . . . Tamiflu

BMJ 2016; 353 doi: (Published 01 June 2016) Cite this as: BMJ 2016;353:i3064
  1. Nigel Hawkes
  1. London

Oh dear, I feel a headache coming on: Tamiflu’s back in the news.

Yes, indeed. A new Cochrane analysis has found insufficient evidence to show that it saved lives in the 2009 H1N1 flu epidemic.1

So we wasted a ton of money, right?

The United Kingdom spent £424m (€550m; $613m) on stockpiling oseltamivir (Tamiflu). The Cochrane team says that it reduced the length of the infection in adults by 16.8 hours and in otherwise healthy children by …

View Full Text

Log in

Log in through your institution


* For online subscription